000 01336 a2200397 4500
005 20250511195519.0
264 0 _c19910905
008 199109s 0 0 eng d
022 _a0016-5085
024 7 _a10.1016/0016-5085(91)90519-q
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLabayle, D
245 0 0 _aSulindac causes regression of rectal polyps in familial adenomatous polyposis.
_h[electronic resource]
260 _bGastroenterology
_cSep 1991
300 _a635-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdenomatous Polyposis Coli
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aRectal Neoplasms
_xchemistry
650 0 4 _aRemission Induction
650 0 4 _aSulindac
_xtherapeutic use
700 1 _aFischer, D
700 1 _aVielh, P
700 1 _aDrouhin, F
700 1 _aPariente, A
700 1 _aBories, C
700 1 _aDuhamel, O
700 1 _aTrousset, M
700 1 _aAttali, P
773 0 _tGastroenterology
_gvol. 101
_gno. 3
_gp. 635-9
856 4 0 _uhttps://doi.org/10.1016/0016-5085(91)90519-q
_zAvailable from publisher's website
999 _c1656792
_d1656792